ATE483471T1 - Kokzidioseimpfstoff sowie verfahren zu seiner herstellung und verwendung - Google Patents

Kokzidioseimpfstoff sowie verfahren zu seiner herstellung und verwendung

Info

Publication number
ATE483471T1
ATE483471T1 AT03796784T AT03796784T ATE483471T1 AT E483471 T1 ATE483471 T1 AT E483471T1 AT 03796784 T AT03796784 T AT 03796784T AT 03796784 T AT03796784 T AT 03796784T AT E483471 T1 ATE483471 T1 AT E483471T1
Authority
AT
Austria
Prior art keywords
production
vaccine
coccidiosis
coccidiosis vaccine
acervulina
Prior art date
Application number
AT03796784T
Other languages
English (en)
Inventor
Larry Mcdougald
Alberta Fuller
Original Assignee
Univ Georgia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia filed Critical Univ Georgia
Application granted granted Critical
Publication of ATE483471T1 publication Critical patent/ATE483471T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03796784T 2002-12-09 2003-12-08 Kokzidioseimpfstoff sowie verfahren zu seiner herstellung und verwendung ATE483471T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43229802P 2002-12-09 2002-12-09
PCT/US2003/038903 WO2004052393A1 (en) 2002-12-09 2003-12-08 Coccidial vaccine and methods of making and using same

Publications (1)

Publication Number Publication Date
ATE483471T1 true ATE483471T1 (de) 2010-10-15

Family

ID=32507887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03796784T ATE483471T1 (de) 2002-12-09 2003-12-08 Kokzidioseimpfstoff sowie verfahren zu seiner herstellung und verwendung

Country Status (14)

Country Link
US (2) US6908620B2 (de)
EP (1) EP1569687B1 (de)
JP (1) JP2006510671A (de)
KR (1) KR20050098837A (de)
CN (1) CN100366290C (de)
AT (1) ATE483471T1 (de)
AU (1) AU2003297719A1 (de)
BR (1) BR0317144A (de)
CA (1) CA2508757C (de)
DE (1) DE60334489D1 (de)
MX (1) MXPA05006121A (de)
RU (1) RU2324498C2 (de)
UA (1) UA87815C2 (de)
WO (1) WO2004052393A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0831897T3 (da) * 1995-06-07 2001-04-30 Pfizer In ovo-vaccination mod coccidiosis
TWI348376B (en) * 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
US7354593B2 (en) * 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
US7879342B2 (en) * 2004-03-12 2011-02-01 Univ. Of Georgia Research Foundation, Inc. Vaccine adjuvant and making and using the same
DE602005021873D1 (de) 2004-03-12 2010-07-29 Univ Georgia Neues impfstoffadjuvans und dessen herstellung und verwendung
US7087425B2 (en) * 2004-03-31 2006-08-08 Embrex, Inc. Method of purifying oocysts using enzymatic digestion of fecal debris
CA2738682A1 (en) 2004-04-15 2005-10-15 Eng-Hong Lee Soft gel delivery system for treating poultry
MX2007012784A (es) * 2005-04-15 2008-01-11 Univ Georgia Res Found Vacuna coccidial y metodos para elaborarla y usarla.
MX2008013451A (es) * 2006-04-17 2008-10-30 Schering Plough Ltd Organismos clostridium atenuados recombinantes y vacuna.
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
CN101024076B (zh) * 2007-03-29 2010-08-18 中国农业大学 球虫的新用途
MX2010012869A (es) * 2008-05-29 2010-12-14 Intervet Int Bv Vacunas contra coccidiosis.
MX2011005133A (es) 2008-11-13 2011-08-04 Intervet Int Bv Vacuna contra eimeria para pavos.
BR112014003950B1 (pt) 2011-08-24 2022-01-11 Dupont Nutrition Biosciences Aps. Uso de cepas de bacillus isoladas produtoras de enzima e alimentação de um animal
CN104936583A (zh) * 2012-06-27 2015-09-23 凯敏工业公司 具有抗球虫活性的植物部分及提取物
US20190000950A1 (en) 2015-12-29 2019-01-03 Intervet Inc. Coccidiosis vaccine
US20180208885A1 (en) 2017-01-24 2018-07-26 Mary Ann Pfannenstiel Antibiotic-free compositions for the prevention or control of coccidiosis
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
CN110170049B (zh) * 2019-06-01 2023-07-04 山西农业大学 一种用于鸡球虫病活疫苗的细胞因子基因佐剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5279960A (en) * 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
ES2054679T3 (es) * 1986-08-18 1994-08-16 British Tech Group Vacunas.
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
US5068104A (en) * 1988-08-01 1991-11-26 A. H. Robins Company Incorporated Live vaccine for coccidiosis utilizing coccidial sporozoites
ZA902147B (en) * 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
ATE94208T1 (de) * 1989-06-21 1993-09-15 Akzo Nv Eimeria tenella-vakzin.
EP0575317B1 (de) * 1991-03-14 1996-08-14 British Technology Group Usa Inc. Rekombinante vakzine gegen coccidiose
ES2137190T3 (es) * 1991-07-12 1999-12-16 Pfizer Linea de celulas continua y vacuna contra los coccidios aviarios.
AU5989894A (en) * 1993-01-19 1994-08-15 Merck & Co., Inc. Live coccidiosis vaccine
EP0653489B1 (de) * 1993-11-12 2003-02-19 Akzo Nobel N.V. Impfstoff gegen Geflügelkokzidose
NZ272945A (en) * 1994-09-16 1997-12-19 Akzo Nobel Nv Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use
ES2158108T3 (es) * 1995-06-07 2001-09-01 Pfizer Vacunacion in ovo contra la coccidiosis.
ES2253746T3 (es) * 1995-07-03 2006-06-01 Akzo Nobel N.V. Vacuna contra la coccidiosis aviar.
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis

Also Published As

Publication number Publication date
DE60334489D1 (de) 2010-11-18
RU2005121517A (ru) 2006-01-20
CN1735429A (zh) 2006-02-15
US20040120973A1 (en) 2004-06-24
UA87815C2 (ru) 2009-08-25
WO2004052393A1 (en) 2004-06-24
EP1569687A1 (de) 2005-09-07
CN100366290C (zh) 2008-02-06
US6908620B2 (en) 2005-06-21
CA2508757C (en) 2011-02-15
AU2003297719A1 (en) 2004-06-30
KR20050098837A (ko) 2005-10-12
JP2006510671A (ja) 2006-03-30
HK1087006A1 (zh) 2006-10-06
CA2508757A1 (en) 2004-06-24
US6998127B2 (en) 2006-02-14
US20050186228A1 (en) 2005-08-25
BR0317144A (pt) 2005-10-25
MXPA05006121A (es) 2005-09-30
EP1569687B1 (de) 2010-10-06
RU2324498C2 (ru) 2008-05-20
EP1569687A4 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
ATE483471T1 (de) Kokzidioseimpfstoff sowie verfahren zu seiner herstellung und verwendung
IL165120A0 (en) A medical implant with a coating to inhibit infection
RU2010153992A (ru) Кокцидиозные вакцины
UA86760C2 (ru) Замещенные n-арилгетероциклы, способ их получения и их применение в качестве лекарственных средств
ATE537826T1 (de) Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
WO2013103642A3 (en) Method and apparatus for identification
EP2168440A4 (de) Equolhaltiges extrakt, herstellungsverfahren dafür, verfahren zur equolextraktion und equolhaltiges nahrungsmittel
BRPI0414443A (pt) imunógenos consensuais/ancestrais
MX2023002792A (es) Preparacion farmaceutica.
ITMI20040031A1 (it) Processo per la preparazione di dispersori di fluoropolimeri
EP2680445A3 (de) Kodeverarbeitungstechnik
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
EP1421178A4 (de) Verbesserte verfahren zur herstellung von oozysten
PL1928836T3 (pl) Podstawione 4-fenylotetrahydroizochinoliny, sposób ich wytwarzania, zastosowanie jako lek oraz lek je zawierający
MX344544B (es) Vacuna para paludismo en etapa sanguinea.
IL307274A (en) Substituted 1-aryl-1'-heteroaryl compounds, substituted 1,1'-biheteroaryl compounds, and methods using same
WO2010025558A8 (en) Triazolium and imidazolium salts and uses thereof
EP1481689A4 (de) Mittel zur stimulierung des haarwachstums, perkutane zubereitungen und verfahren zur stimulierung des haarwachstums
EA200500775A1 (ru) Эфиры карбаминовой кислоты, обладающие антихолинергическим действием
WO2010056709A3 (en) Eimeria vaccine for turkeys
EP4625409A4 (de) Sprachinteraktionsverfahren und -vorrichtung sowie zugehörige vorrichtung
ATE359815T1 (de) Streptococcus-phocae-vakzine
NO20054545L (no) Fremgangsmate for fremstiilling av ferutinin fra Ferula genusplanter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties